Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EPS (Weighted Average and Diluted) (2024 - 2025)

Beta Bionics' EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$0.25 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 90.74% year-over-year to -$0.25; the TTM value through Dec 2025 reached -$1.81, up 78.95%, while the annual FY2025 figure was -$1.81, 78.95% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.25 at Beta Bionics, up from -$0.33 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.25 in Q4 2025 and bottomed at -$2.7 in Q4 2024.